INVA
Innoviva, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.26
+1.58%Forward multiples
Based on analyst estimates
- P/E forward
- 9.72x
- P/E 2026E
- 8.82x
- P/E 2027E
- 9.43x
- P/E 2028E
- 10.83x
- P/S forward
- 3.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.37x
- PEG TTM
- 0.34x
- Price / book
- 1.25x
- Price / sales
- 3.46x
- Price / cash flow
- 8.02x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.77x
- EV / EBITDA
- 1.59x
- EV / EBIT
- 7.54x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026